NHS
Corbyn reveals documents showing US-UK meetings on deregulating NHS drug pricing
November 27, 2019Research and Development, Sales and Marketing Jeremy Corbyn, Labour Party, NHS, US, pharma
Labour Leader Jeremy Corbyn has showed off documents that detail secret trade meetings between the US and UK Governments, where …
Vertex’s cystic fibrosis portfolio to be made available across Northern Ireland and Wales
November 13, 2019Research and Development, Sales and Marketing Kalydeco, NHS, Orkambi, Symkevi, Vertex, pharma
After drawn out negotiations and much discontent among cystic fibrosis (CF) patients and their advocates, Vertex has announced that a …
Scottish Medicines Consortium recommends Eisai’s Kisplyx for advanced kidney cancer
November 12, 2019Manufacturing and Production, Sales and Marketing Eisai, Kisplyx, NHS, Sotland, pharma
Eisai’s Kisplyx (lenvatinib) has secured recommendation from the Scottish Medicines Consortium, it has been revealed, meaning that patients on the …
Novartis’ Kisqali approved for NHS Scotland in most common advanced breast cancer
November 12, 2019Manufacturing and Production, Sales and Marketing Cancer, Kisqali, NHS, Novartis, Scotland, breast cancer, pharma
NHS patients in Scotland will soon be able to access Novartis’ CDK4/6 inhibitor Kisqali (ribociclib) after the Scottish Medicines Consortium …
NHS to utilise first-ever cannabis-based therapies following NICE recommendation of two GW Pharma drugs
November 11, 2019Sales and Marketing Epidyolex, GW Pharma, NHS, Sativex, pharma
The NHS is authorised to use its first two cannabis-based medicines for routine use after NICE saw fit to recommend …
Clovis Oncology’s Rubraca now available via the Cancer Drugs Fund for ovarian, peritoneal, fallopian tube cancer
October 11, 2019Medical Communications, Sales and Marketing Cancer, Clovis Oncology, NHS, NICE, Rubraca, fallopian tube cancer, ovarian cancer, peritoneal cancer, pharma
NICE has announced it has made an about-face on its earlier ruling for Clovis Oncology’s Rubraca (rucaparib), revealing that the …
NICE recommends pentosan polysulfate sodium for NHS treatment of bladder pain syndrome
October 10, 2019Sales and Marketing NHS, NICE, bladder pain syndrome, pentosan polysulfate sodium
NICE has chosen to recommend pentosan polysulfate sodium, it has emerged, for use on the NHS in the treatment of …
Gilead’s CAR-T therapy Yescarta now available via NHS Scotland for two forms of B-cell lymphoma
October 8, 2019Manufacturing and Production, Sales and Marketing CAR T, CAR-T, NHS, Scotland, Scottish Medicines Consortium, pharma
News has broken that the Scottish Medicines Consortium (SMC) has chosen to approve the use of Gilead’s chimeric antigen receptor …
Scotland approves first-line NHS use of MSD’s Keytruda combo for advanced non-small cell lung cancer
October 7, 2019Sales and Marketing Cancer, NHS, Scotland, Scottish Medicines Consortium, UK, keytruda, lung cancer, pharma
The Scottish Medicines Consortium (SMC) has announced its decision to accept MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) in combination with pemetrexed …
NICE recommends Takeda’s Takhzyro for NHS use to prevent hereditary angioedema attacks
September 18, 2019Research and Development, Sales and Marketing NHS, NICE, Takeda, Takhzyro, pharma
UK drug watchdog NICE has announced its final draft guidance recommending Takeda’s subcutaneous injection Takhzyro (Lanadelumab) for use on the …
NICE recommends Novartis’ gene therapy Luxturna for inherited retinal dystrophy
September 4, 2019Research and Development, Sales and Marketing Luxturna, NHS, NICE, UK, gene therapy, pharma
NICE has chosen to recommend the use of Novartis’ one-time gene therapy Luxturna (voretigene neparvovec) for use on the NHS …
No-deal Brexit will “make the disintegration of the health service an ever more real prospect”, BMA warns
September 2, 2019Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMA, NHS, UK, brexit, pharma
As the UK hurtles towards a catastrophic and autocratic exit from the European Union, the British Medical Association (BMA) has …
NICE Chief Sir Andrew Dillon to step down in 2020
August 22, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK pharma, UK< pharma
It’s the end of an era at the National Institute of Health and Care Excellence (NICE), the UK watchdog responsible …
Hundreds of patients turn to private cannabis clinics in UK
August 16, 2019Medical Communications Marijuana, NHS, UK, cannabis, medicinal cannabis, pharma
Hundreds of people have turned to private clinics, in an effort to gain access to medicinal cannabis in the UK, …
Aspen Pharmacare to pay £8 million after colluding to rip off NHS
August 14, 2019Research and Development Addison's disease, Aspen Pharmacare, CMA, NHS, pharma
South African firm Aspen Pharmacare has agreed to pay £8 million to Britain’s NHS over a dispute about overpayment. The …
